{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:42:43Z","timestamp":1788298963320,"version":"build-2803163510"},"reference-count":80,"publisher":"Impact Journals, LLC","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2020,12,22]]},"DOI":"10.18632\/oncotarget.27842","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T16:01:16Z","timestamp":1608652876000},"page":"4754-4769","source":"Crossref","is-referenced-by-count":12,"title":["Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme"],"prefix":"10.18632","volume":"11","author":[{"given":"Vishnu S.","family":"Mishra","sequence":"first","affiliation":[{"name":"Precision NeuroOncology & NeuroVascular Disease Modeling Group, Department of Life Sciences, School of Natural Sciences, Shiv Nadar University, NCR, 201314, India"},{"name":"These authors contributed equally to this work"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kumar","sequence":"additional","affiliation":[{"name":"Precision NeuroOncology & NeuroVascular Disease Modeling Group, Department of Life Sciences, School of Natural Sciences, Shiv Nadar University, NCR, 201314, India"},{"name":"These authors contributed equally to this work"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoom","family":"Raza","sequence":"additional","affiliation":[{"name":"Precision NeuroOncology & NeuroVascular Disease Modeling Group, Department of Life Sciences, School of Natural Sciences, Shiv Nadar University, NCR, 201314, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Sehrawat","sequence":"additional","affiliation":[{"name":"Precision NeuroOncology & NeuroVascular Disease Modeling Group, Department of Life Sciences, School of Natural Sciences, Shiv Nadar University, NCR, 201314, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","reference":[{"key":"1","unstructured":"WHO. GLOBOCAN 2018-HOME. 2018. https:\/\/gco.iarc.fr\/."},{"key":"2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/nejmoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"35","author":"et","year":"2005","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","article-title":"A restricted cell population propagates glioblastoma growth after chemotherapy","volume":"48","author":"Parada","year":"2012","journal-title":"Nature"},{"key":"4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/nejmra0708126","article-title":"Malignant gliomas in adults","volume":"35","author":"Kesari","year":"2008","journal-title":"N Engl J Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrn2175","article-title":"Angiogenesis in brain tumours","volume":"8","author":"Batchelor","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"6","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1158\/1078-0432.ccr-06-2309","article-title":"Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma","volume":"1","author":"Friedman","year":"2007","journal-title":"Clin Cancer Res"},{"key":"7","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.bbagen.2012.10.008","article-title":"The cancer stem cell niche (s): the crosstalk between glioma stem cells and their microenvironment","volume":"183","author":"Garvalov","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"44","author":"Rich","year":"2006","journal-title":"Nature"},{"key":"9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/sj.cdd.4401872","article-title":"Chemotherapy resistance of glioblastoma stem cells","volume":"1","author":"De Maria","year":"2006","journal-title":"Cell Death Differ"},{"key":"10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1158\/0008-5472.can-10-2743","article-title":"Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP","volume":"7","author":"Hollingsworth","year":"2011","journal-title":"Cancer Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"517172","DOI":"10.1155\/2012\/517172","article-title":"CD24 expression as a marker for predicting clinical outcome in human gliomas","volume":"201","author":"Zhao","year":"2012","journal-title":"BioMed Research International"},{"key":"12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10555-018-9766-5","article-title":"Perspectives on the role of brain cellular players in cancer-associated brain metastasis: translational approach to understand molecular mechanism of tumor progression","volume":"3","author":"Sehrawat","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fimmu.2016.00156","article-title":"Role of redox status in development of glioblastoma","volume":"7","author":"Pineda","year":"2016","journal-title":"Front Immunol"},{"key":"14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.12703\/p6-46","article-title":"Advances in treating glioblastoma","volume":"6","author":"Gilbert","year":"2014","journal-title":"F1000Prime Rep"},{"key":"15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00109-009-0440-9","article-title":"Tumor initiating cells in malignant gliomas: biology and implications for therapy","volume":"8","author":"Van Meir","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-017-0670-3","article-title":"Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development","volume":"1","author":"Li","year":"2017","journal-title":"Mol Cancer"},{"key":"17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/neuonc\/nos117","article-title":"Current clinical development of PI3K pathway inhibitors in glioblastoma","volume":"1","author":"Alfred Yung","year":"2012","journal-title":"Neuro-oncol"},{"key":"18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The Polycomb group protein EZH2 directly controls DNA methylation","volume":"43","author":"Di Croce","year":"2006","journal-title":"Nature"},{"key":"19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7150\/ijbs.8.59","article-title":"EZH2 methyltransferase and H3K27 methylation in breast cancer","volume":"8","author":"Hennighausen","year":"2012","journal-title":"Int J Biol Sci"},{"key":"20","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1038\/ncomms7051","article-title":"The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors","volume":"6","author":"Levesque","year":"2015","journal-title":"Nat Commun"},{"key":"21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1021\/cb400133j","article-title":"An orally bioavailable chemical probe of the lysine methyltransferases EZH2 and EZH1","volume":"8","author":"Pattenden","year":"2013","journal-title":"ACS Chem Biol"},{"key":"22","doi-asserted-by":"publisher","first-page":"110415","DOI":"10.18632\/oncotarget.22780","article-title":"Smad1 promotes colorectal cancer cell migration through Ajuba transactivation","volume":"8","author":"Jia","year":"2017","journal-title":"Oncotarget"},{"key":"23","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.4161\/cc.9.15.12335","article-title":"Parole terms for a killer: Directing the caspase3\/CAD induced DNA strand breaks to coordinate changes in gene expression","volume":"9","author":"Megeney","year":"2010","journal-title":"Cell Cycle"},{"key":"24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12885-019-5587-3","article-title":"Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labeling","volume":"1","author":"Telleria","year":"2019","journal-title":"BMC Cancer"},{"key":"25","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of matrix metalloproteinases in angiogenesis and cancer","volume":"9","author":"Alvarez Sanchez","year":"2019","journal-title":"Front Oncol"},{"key":"26","first-page":"30","article-title":"A survey on the role of interleukin-10 in breast cancer: A narrative","volume":"7","author":"Neamatzadeh","year":"2018","journal-title":"Rep Biochem Mol Biol"},{"key":"27","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.3390\/cancers3022050","article-title":"Wnt\/\u03b2-catenin Signaling in Normal and Cancer Stem Cells","volume":"3","author":"Williams","year":"2011","journal-title":"Cancers (Basel)"},{"key":"28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/15680096113136660102","article-title":"The role of snail in EMT and tumorigenesis","volume":"1","author":"Zhou","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"29","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1242\/dev.01907","article-title":"The Snail genes as inducers of cell movement and survival: implications in development and cancer","volume":"13","author":"Nieto","year":"2005","journal-title":"Development"},{"key":"30","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/glia.21185","article-title":"Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy","volume":"5","author":"Rich","year":"2011","journal-title":"Glia"},{"key":"31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrn3765","article-title":"A neurocentric perspective on glioma invasion","volume":"1","author":"Sontheimer","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-7091-6090-9_23","article-title":"Invasion as limitation to anti-angiogenic glioma therapy","volume":"8","author":"Westphal","year":"2003","journal-title":"Acta Neurochir Suppl"},{"key":"33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4103\/0974-8237.77678","article-title":"Supratentorial glioblastoma multiforme with spinal metastases","volume":"1","author":"Goel","year":"2010","journal-title":"J Craniovertebr Junction Spine"},{"key":"34","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/00006123-199010000-00002","article-title":"Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series","volume":"2","author":"Selker","year":"1990","journal-title":"Neurosurgery"},{"key":"35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1158\/1535-7163.mct-16-0413","article-title":"MENA confers resistance to paclitaxel in triple-negative breast cancer","volume":"1","author":"Gertler","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrc.2017.18","article-title":"The calcium-cancer signalling nexus","volume":"1","author":"Roberts-Thomson","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"37","doi-asserted-by":"publisher","first-page":"31666","DOI":"10.1074\/jbc.r112.343061","article-title":"Calcium channels and pumps in cancer: changes and consequences","volume":"28","author":"Roberts-Thomson","year":"2012","journal-title":"J Biol Chem"},{"key":"38","doi-asserted-by":"publisher","first-page":"8904","DOI":"10.1073\/pnas.1533394100","article-title":"Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2","volume":"10","author":"Cheng","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"39","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/ijms19041057","article-title":"Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer","volume":"1","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"40","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/jir.2018.0044","article-title":"Interleukin-33 and ST2 signaling in tumor microenvironment","volume":"3","author":"Lin","year":"2019","journal-title":"J Interferon Cytokine Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-030-38315-2_7","article-title":"ST2 Signaling in the Tumor Microenvironment","volume":"124","author":"Wang","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0092-8674(92)90180-k","article-title":"Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease","volume":"6","author":"Stein","year":"1992","journal-title":"Cell"},{"key":"43","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/0092-8674(93)90361-s","article-title":"CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF","volume":"7","author":"McAlister","year":"1993","journal-title":"Cell"},{"key":"44","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1038\/bcj.2017.85","article-title":"Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions","volume":"7","author":"Prince","year":"2017","journal-title":"Blood Cancer J"},{"key":"45","first-page":"1153","article-title":"IL24 and its Receptors Regulate Growth and Migration of Pancreatic Cancer Cells and Are Potential Biomarkers for IL24 Molecular Therapy","volume":"3","author":"Jiang","year":"2016","journal-title":"Anticancer Res"},{"key":"46","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.ymthe.2004.08.020","article-title":"Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism","volume":"1","author":"Ekmekcioglu","year":"2004","journal-title":"Mol Ther"},{"key":"47","doi-asserted-by":"publisher","first-page":"10332","DOI":"10.1073\/pnas.171315198","article-title":"A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells","volume":"9","author":"Fisher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/sj.onc.1206062","article-title":"Melanoma differentiation associated gene-7, mda-7\/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner","volume":"2","author":"Fisher","year":"2003","journal-title":"Oncogene"},{"key":"49","first-page":"3272","article-title":"Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cellsand","volume":"9","author":"Grant","year":"2003","journal-title":"Clin Cancer Res"},{"key":"50","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/cco.0000000000000006","article-title":"Current status of IL-10 and regulatory T-cells in cancer","volume":"2","author":"Khazaie","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"51","unstructured":"AANS. Glioblastoma Multiforme. American Association of Neurological Surgeons. https:\/\/www.aans.org\/en\/Patients\/Neurosurgical-Conditions-and-Treatments\/Glioblastoma-Multiforme."},{"key":"52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0090-3019(99)00177-9","article-title":"Brain tumors in Mexico: characteristics and prognosis of glioblastoma","volume":"5","author":"Sotelo","year":"2000","journal-title":"Surg Neurol Int"},{"key":"53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1215\/15228517-2008-078","article-title":"New (alternative) temozolomide regimens for the treatment of glioma","volume":"1","author":"Weller","year":"2009","journal-title":"Neuro-oncol"},{"key":"54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"1","author":"Zhao","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"2","author":"Roberts","year":"2016","journal-title":"Nat Med"},{"key":"56","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"46","author":"Bartek","year":"2009","journal-title":"Nature"},{"key":"57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbcan.2015.06.009","article-title":"Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment","volume":"186","author":"Van Ginderachter","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"58","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/ars.2007.1830","article-title":"DNA damage and repair: from molecular mechanisms to health implications","volume":"1","author":"Chichiarelli","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10014-013-0149-x","article-title":"Pathological features of highly invasive glioma stem cells in a mouse xenograft model","volume":"3","author":"Suzuki","year":"2014","journal-title":"Brain Tumor Pathol"},{"key":"60","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bbrc.2011.02.123","article-title":"Elevated invasive potential of glioblastoma stem cells","volume":"40","author":"Bao","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"61","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1158\/0008-5472.can-17-2464","article-title":"Inhibition of translesion DNA synthesis as a novel therapeutic strategy to treat brain cancer","volume":"7","author":"Berdis","year":"2018","journal-title":"Cancer Res"},{"key":"62","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"43","author":"Dirks","year":"2004","journal-title":"Nature"},{"key":"63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1476-4598-5-67","article-title":"Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma","volume":"5","author":"Yu","year":"2006","journal-title":"Mol Cancer"},{"key":"64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40169-018-0211-8","article-title":"Combination therapy to checkmate Glioblastoma: clinical challenges and advances","volume":"7","author":"Bhattacharjee","year":"2018","journal-title":"Clin Transl Med"},{"key":"65","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.biopha.2017.05.125","article-title":"Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review","volume":"9","author":"Hassan","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"66","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1021\/acschemneuro.8b00339","article-title":"Brain targeting by liposome-biomolecular corona boosts anticancer efficacy of temozolomide in glioblastoma cells","volume":"9","author":"Caracciolo","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"67","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4010629","article-title":"Therapeutic potential of thymoquinone in glioblastoma treatment: targeting major gliomagenesis signaling pathways","volume":"201","author":"Bin Sayeed","year":"2018","journal-title":"BioMed Res Int"},{"key":"68","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3892\/ol.2018.8727","article-title":"MicroRNA-599 suppresses glioma progression by targeting RAB27B","volume":"1","author":"Lai","year":"2018","journal-title":"Oncol Lett"},{"key":"69","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/onc.2013.61","article-title":"An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells","volume":"3","author":"Stetler-Stevenson","year":"2014","journal-title":"Oncogene"},{"key":"70","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/bjc.2017.362","article-title":"Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion","volume":"11","author":"Chiang","year":"2017","journal-title":"Br J Cancer"},{"key":"71","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/1097-0142(20010901)92:5%3C1138::aid-cncr1431%3E3.0.co;2-l","article-title":"Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis","volume":"9","author":"Ellis","year":"2001","journal-title":"Cancer"},{"key":"72","first-page":"1255","article-title":"The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer","volume":"6","author":"Ellis","year":"2001","journal-title":"Cancer Res"},{"key":"73","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ijc.10851","article-title":"Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival","volume":"10","author":"De Bortoli","year":"2003","journal-title":"Int J Cancer"},{"key":"74","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13287-018-0977-z","article-title":"Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas","volume":"9","author":"Fu","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"75","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1517\/14740330902918281","article-title":"The safety of temozolomide in the treatment of malignancies","volume":"8","author":"Hwu","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"76","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Yeger","year":"2017","journal-title":"Oncotarget"},{"key":"77","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11010-017-2959-3","article-title":"Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis","volume":"43","author":"Sehrawat","year":"2017","journal-title":"Mol Cell Biochem"},{"key":"78","doi-asserted-by":"publisher","first-page":"e997","DOI":"10.21769\/bioprotoc.997","article-title":"Invadopodia detection and gelatin degradation assay","volume":"3","author":"D\u00edaz","year":"2013","journal-title":"Bio Protoc"},{"key":"79","doi-asserted-by":"publisher","first-page":"14577","DOI":"10.1021\/acsami.8b03477","article-title":"Stable dispersions of covalently tethered polymer improved graphene oxide nanoconjugates as an effective vector for siRNA delivery","volume":"1","author":"Lochab","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"80","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/carcin\/bgy090","article-title":"cAMP regulated EPAC1 supports microvascular density, angiogenic and metastatic properties in a model of triple negative breast cancer","volume":"3","author":"Sehrawat","year":"2018","journal-title":"Carcinogenesis"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T16:01:32Z","timestamp":1608652892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":80,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2020,12,22]]}},"alternative-id":["27842"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27842","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,22]]}}}